Tags

Type your tag names separated by a space and hit enter

Fluoroquinolone antibiotics in infants and children.
Infect Dis Clin North Am. 2005 Sep; 19(3):617-28.ID

Abstract

The use of fluoroquinolones in children is limited because of the potential of these agents to induce arthropathy in juvenile animals and to potentiate development of bacterial resistance. No quinolone-induced cartilage toxicity as described in animal experiments has been documented unequivocally in patients, but the risk fro rapid emergence of bacterial resistance associated with widespread, uncontrolled fluoroquinolones use in children is a realistic threat. Overall, the fluoroquinolones have been safe and effective in the treatment of selected bacterial infections in pediatric patients. There are clearly defined indications for these compounds in children who are ill.

Authors+Show Affiliations

Department of Pediatrics, University Children's Hospital UKBB, Basel, Switzerland. urs-b.schaad@unibas.ch

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16102652

Citation

Schaad, Urs B.. "Fluoroquinolone Antibiotics in Infants and Children." Infectious Disease Clinics of North America, vol. 19, no. 3, 2005, pp. 617-28.
Schaad UB. Fluoroquinolone antibiotics in infants and children. Infect Dis Clin North Am. 2005;19(3):617-28.
Schaad, U. B. (2005). Fluoroquinolone antibiotics in infants and children. Infectious Disease Clinics of North America, 19(3), 617-28.
Schaad UB. Fluoroquinolone Antibiotics in Infants and Children. Infect Dis Clin North Am. 2005;19(3):617-28. PubMed PMID: 16102652.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Fluoroquinolone antibiotics in infants and children. A1 - Schaad,Urs B, PY - 2005/8/17/pubmed PY - 2006/2/1/medline PY - 2005/8/17/entrez SP - 617 EP - 28 JF - Infectious disease clinics of North America JO - Infect Dis Clin North Am VL - 19 IS - 3 N2 - The use of fluoroquinolones in children is limited because of the potential of these agents to induce arthropathy in juvenile animals and to potentiate development of bacterial resistance. No quinolone-induced cartilage toxicity as described in animal experiments has been documented unequivocally in patients, but the risk fro rapid emergence of bacterial resistance associated with widespread, uncontrolled fluoroquinolones use in children is a realistic threat. Overall, the fluoroquinolones have been safe and effective in the treatment of selected bacterial infections in pediatric patients. There are clearly defined indications for these compounds in children who are ill. SN - 0891-5520 UR - https://www.unboundmedicine.com/medline/citation/16102652/Fluoroquinolone_antibiotics_in_infants_and_children_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-5520(05)00041-3 DB - PRIME DP - Unbound Medicine ER -